Overexpression of the far upstream element binding protein 1 in hepatocellular carcinoma is required for tumor growth
Open Access
- 29 May 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 50 (4), 1121-1129
- https://doi.org/10.1002/hep.23098
Abstract
We identified the far upstream element binding protein 1 (FBP1), an activator of transcription of the proto‐oncogene c‐myc, in a functional yeast survival screen for tumor‐related antiapoptotic proteins and demonstrated strong overexpression of FBP1 in human hepatocellular carcinoma (HCC). Knockdown of the protein in HCC cells resulted in increased sensitivity to apoptotic stimuli, reduced cell proliferation, and impaired tumor formation in a mouse xenograft transplantation model. Interestingly, analysis of gene regulation in these cells revealed that c‐myc levels were not influenced by FBP1 in HCC cells. Instead, we identified the cell cycle inhibitor p21 as a direct target gene repressed by FBP1, and in addition, expression levels of the proapoptotic genes tumor necrosis factor α, tumor necrosis factor–related apoptosis‐inducing ligand, Noxa, and Bik were elevated in the absence of FBP1. Conclusion: Our data establish FBP1 as an important oncoprotein overexpressed in HCC that induces tumor propagation through direct or indirect repression of cell cycle inhibitors and proapoptotic target genes. (HEPATOLOGY 2009.)Keywords
This publication has 32 references indexed in Scilit:
- Hierarchical mechanisms build the DNA-binding specificity of FUSE binding proteinProceedings of the National Academy of Sciences of the United States of America, 2008
- Molecular targeted therapies in hepatocellular carcinomaHepatology, 2008
- The FUSE Binding Protein Is a Cellular Factor Required for Efficient Replication of Hepatitis C VirusJournal of Virology, 2008
- Contradictory functions of NF-κB in liver physiology and cancerCancer Letters, 2008
- Dimerization of FIR upon FUSE DNA binding suggests a mechanism of c-myc inhibitionThe EMBO Journal, 2007
- P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resectionLiver International, 2007
- FBPs Are Calibrated Molecular Tools To Adjust Gene ExpressionMolecular and Cellular Biology, 2006
- The FUSE/FBP/FIR/TFIIH system is a molecular machine programming a pulse of c-myc expressionThe EMBO Journal, 2006
- The Hallmarks of CancerCell, 2000
- Amplification and Overexpression of Cyclin D1 in Human Hepatocellular CarcinomaBiochemical and Biophysical Research Communications, 1993